NovaQuest Closes New PE Fund With $275 Million

Holly Buckley
McGuireWoods LLP
Contact
LinkedIn
Facebook
X
Send
Embed

NovaQuest Private Equity has reached its hard cap of $275 million in capital commitments for a new private equity (PE) fund, according to a news release.

NovaQuest Private Equity Fund I targets tech-enabled healthcare solutions and pharmaceutical services investments.

NovaQuest Private Equity is the PE group of NovaQuest Capital Management. Based in Raleigh, N.C., and formed in 2000, NovaQuest Capital Management provides strategic capital to life science and healthcare companies.

The firm stated it has already completed three platform investments and two add-on acquisitions out of its new PE fund, including investments in Azurity Pharmaceuticals, Clinical Ink and Catalyst Clinical Research.

Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide